Updated results from OCTAVIA (front-line bevacizumab, carboplatin and weekly paclitaxel therapy for ovarian cancer).
暂无分享,去创建一个
S. Pignata | G. Scambia | A. Oaknin | L. Gladieff | B. Tholander | U. Freudensprung | M. Gore | A. González-Martín | D. Stroyakovsky | V. Sneller